Pfizer PFE
NYSE PFE
$29.24 -0.15 (-0.51%)
At close: Nov 9, 2026 · 4:00 PM EST

Pfizer (PFE) Restructuring Costs (2009 - 2026)

Updated

Pfizer (PFE) reported Restructuring Costs of $791 million for Q3 2026, up 176.6% from $286 million a year earlier and up 73.1% from the prior quarter.

Analysis

Pfizer (PFE) Restructuring Costs (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 27, 2026, Pfizer's Restructuring Costs came in at $1.95 billion, up 19.1% year-over-year; for FY2025, it came in at $1.55 billion, down 35.9% from FY2024.

  • Restructuring Costs has a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
  • By year, Restructuring Costs came in at $2.42 billion in FY2024 (-17.8%), $2.94 billion in FY2023 (+114.0%), $1.38 billion in FY2022 (+71.4%) and $802 million in FY2021 (+38.5%).
  • The Q3 2026 figure ranks as the highest quarterly Restructuring Costs since Q2 2024.
  • Year over year, Restructuring Costs gained in two of the last six quarters, with growth averaging 92.9%.
  • The high point for year-over-year Restructuring Costs in five years was Q1 2022 (growth of 772.7%); the low point was Q1 2026 (a decline of 85.3%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $457 million (Q2 2026), $100 million (Q1 2026) and $605 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Vertex Pharmaceuticals 139.96 Bn 111.95 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 791.00 Mn
Jun 28, 2026 457.00 Mn
Mar 29, 2026 100.00 Mn
Dec 31, 2025 605.00 Mn
Sep 28, 2025 286.00 Mn
Jun 29, 2025 -74.00 Mn
Mar 30, 2025 678.00 Mn
Dec 31, 2024 750.00 Mn
Sep 29, 2024 313.00 Mn
Jun 30, 2024 1.25 Bn
Mar 31, 2024 102.00 Mn
Dec 31, 2023 2.57 Bn
Oct 1, 2023 155.00 Mn
Jul 2, 2023 214.00 Mn
Apr 2, 2023 -44.00 Mn
Dec 31, 2022 795.00 Mn
Oct 2, 2022 199.00 Mn
Jul 3, 2022 189.00 Mn
Apr 3, 2022 192.00 Mn
Dec 31, 2021 135.00 Mn
API Access

Pfizer Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PFE&period=max&api_key=YOUR_API_KEY